Novanta insider sales and RSUs disclosed

Novanta, Inc. filing under Rule 144 discloses recent restricted stock unit grants and several secondary sales by a reporting holder.

Rhea-AI Filing Summary

Novanta, Inc. filing under Rule 144 discloses recent restricted stock unit grants and several secondary sales by a reporting holder. The excerpt lists RSU grants dated 02/24/2025 (1,900 shares), 02/28/2020 (2,076 shares) and earlier grants, and four sales by Matthijs Glastra on 01/21/2026, 02/02/2026, 02/10/2026, and 03/02/2026 for 7,500; 6,500; 7,500; and 6,500 shares respectively, with corresponding gross amounts shown.

Key Figures

RSU grant 02/24/2025: 1,900 shares RSU grant 02/28/2020: 2,076 shares Sale 01/21/2026: 7,500 shares +3 more

6 metrics

RSU grant 02/24/2025 1,900 shares Restricted Stock Units dated 02/24/2025

RSU grant 02/28/2020 2,076 shares Restricted Stock Units dated 02/28/2020

Sale 01/21/2026 7,500 shares Sale by Matthijs Glastra on 01/21/2026; gross $1,050,000

Sale 02/02/2026 6,500 shares Sale by Matthijs Glastra on 02/02/2026; gross $877,500

Sale 02/10/2026 7,500 shares Sale by Matthijs Glastra on 02/10/2026; gross $1,087,500

Sale 03/02/2026 6,500 shares Sale by Matthijs Glastra on 03/02/2026; gross $845,000

Key Terms

Restricted Stock Units, Form 144, Selling holder

3 terms

Restricted Stock Units financial

"Restricted Stock Units | Novanta, Inc. | | | 1900 | 02/24/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"CONTENT METADATA: "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Selling holder financial

"Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730 | Common | 01/21/2026 | 7500 | 1050000"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Novanta (NOVT) Form 144 disclose about recent insider sales?

It lists four sales by Matthijs Glastra totaling multiple transactions. The filing shows sales on 01/21/2026 (7,500 shares), 02/02/2026 (6,500), 02/10/2026 (7,500), and 03/02/2026 (6,500), with gross proceeds indicated for each.

Which restricted stock units are noted in the Novanta filing (NOVT)?

The excerpt lists multiple RSU grant dates and amounts. Examples include RSUs dated 02/24/2025 for 1,900 shares, 02/28/2020 for 2,076 shares, 01/01/2021 for 1,662 shares, and earlier grants with listed share counts.

Who is the selling holder named in the Novanta (NOVT) excerpt?

The filing identifies Matthijs Glastra as the selling holder. Sales are reported with an address c/o Novanta, Inc., and include individual sale dates and share counts (7,500; 6,500; 7,500; 6,500).

Are proceeds from the sales shown in the Novanta (NOVT) Form 144 excerpt?

Yes; gross proceeds are listed alongside each sale. Examples: the 01/21/2026 sale of 7,500 shows $1,050,000, 02/02/2026 6,500 shows $877,500, and other dates include corresponding gross amounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 11:05 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001561438
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Novanta, Inc.
SEC File Number
Address of Issuer	C/O Novanta Inc. 125 Middlesex Turnpike Bedford MASSACHUSETTS 01730
Phone	6174489506
Name of Person for Whose Account the Securities are To Be Sold	Matthijs Glastra
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Private Wealth Management 100 Federal Street, 12th Floor Boston MA 02110	6500	845000	35683769	04/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2025	Restricted Stock Units	Novanta, Inc.			1900	02/24/2025	Equity Compensation
Common	01/03/2023	Restricted Stock Units	Novanta, Inc.			241	01/03/2023	Equity Compensation
Common	01/01/2021	Restricted Stock Units	Novanta, Inc.			1662	01/01/2021	Equity Compensation
Common	01/01/2020	Restricted Stock Units	Novanta, Inc.			621	01/01/2020	Equity Compensation
Common	02/28/2020	Restricted Stock Units	Novanta, Inc.			2076	02/28/2020	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	01/21/2026	7500	1050000
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	02/02/2026	6500	877500
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	02/10/2026	7500	1087500
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	03/02/2026	6500	845000

144: Remarks and Signature

Remarks	Shares sold under Matthijs Glastra 2020 Trust U/A DTD 03/09/2020 Matthijs Glastra TTEE and Anna Maria Vogelaar TTEE.
Date of Notice	04/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Matthijs Glastra
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)